According to filings with the U.S. Securities and Exchange Commission, ZealCare, Inc. is raising up to $2,000,000.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.

About ZealCare, Inc.
ZealCare makes changing for better health a lot easier for individuals. We surround every participant with the support of a dedicated health coach, peer group, and delightful digital touchpoints to make small but important shifts. Change is hard. ZealCare has cracked the code on how to help patients dealing with multiple complex conditions sustainably improve their health. We uniquely combine evidence-based strategies that empower, educate, and encourage change through our immersive model.

To learn more about ZealCare, Inc., visit http://zealcare.com/
ZealCare, Inc. Linkedin Page: https://www.linkedin.com/company/zealcareinc/

Contact:
Cassie Wallace, President
919-434-8246
https://www.linkedin.com/in/cgtwallace/

SOURCE: http://www.intelligence360.io
Copyright (c) 2025 SI360 Inc. All rights reserved.